FDA Clearance Tracker · K230852
HemosIL Chromogenic Factor IX
Last checked: Nov 20, 2026Latest source record: Dec 13, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 13, 2023
Substantially Equivalent
Time to decision
260 days
Received Mar 28, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K230852
- Device name
- HemosIL Chromogenic Factor IX
- Applicant
- Instrumentation Laboratory Company
- Applicant location
- Bedford, MA
- Received
- Mar 28, 2023
- Decided
- Dec 13, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 864.7290
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GGP. The earliest in FDA's data is K761058, decided Feb 7, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K230852
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Instrumentation Laboratory Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223608 · Decided Aug 10, 2023 · 251 days after receipt
Device type: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph (CHL) · Laboratory Medicine & Pathology
- ACL TOP Family 70 Series510(k)
K231031 · Decided Jun 21, 2023 · 71 days after receipt
Device type: Instrument, Coagulation, Automated (GKP) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.